-
1 Comment
Medical Net, Inc is currently in a long term uptrend where the price is trading 9.3% above its 200 day moving average.
From a valuation standpoint, the stock is 42.8% cheaper than other stocks from the Communication Services sector with a price to sales ratio of 1.5.
Medical Net, Inc's total revenue rose by 19.7% to $884M since the same quarter in the previous year.
Its net income has increased by 35.9% to $35M since the same quarter in the previous year.
Based on the above factors, Medical Net, Inc gets an overall score of 4/5.
ISIN | AU000000WBT5 |
---|---|
Exchange | TSE |
CurrencyCode | JPY |
Industry | Internet Content & Information |
Sector | Communication Services |
Beta | 0.59 |
---|---|
Market Cap | 3B |
Dividend Yield | 1.9% |
PE Ratio | None |
Target Price | None |
Medical Net, Inc. provides medical and life related information services through Internet. It operates dental implant treatment, orthodontic and aesthetic dental treatment, and dental comprehensive information sites; and offers dental clinic management support services, as well as dental related enterprise marketing support services. The company also operates medical care, beauty, lifestyle, child support, and mother's support related information sites, such as health care information, pet examination, body net, men's esthetic net, LASIK net, petit plastic surgery popularity ranking information, beauty salon ranking information, cosmetic surgery, beauty information, beauty salon search, men's cosmetic surgery, hair loss and anti-aging popularity ranking, detox and supplement popularity ranking, and beauty school overall ranking sites. In addition, it provides web production and marketing support services. The company was formerly known as Medical Net Communications, Inc. and changed its name to Medical Net, Inc. in December 2016. Medical Net, Inc. was founded in 2000 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3645.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025